Introduction
Diuretics, particularly thiazides and their analogs, exert a gradual and stable hypotensive effect when taken once daily. They also have many other benefits, including few absolute contraindications, good compliance and low cost. Therefore, they have long been widely used as antihypertensive drugs. In recent large-scale clinical studies, diuretics have been shown to prevent cardiovascular events, particularly cerebrovascular disorders (1, 2) . At low doses, diuretics are as effective as all other antihypertensive agents for nearly all types of cardiovascular events (2) . Based on these evidences, the 7th Report of the U.S. Joint National Committee on Prevention, Detection, Evaluation and Treatment of Blood Pressure (JNC 7) recommended that thiazide diuretics be used preferentially as the antihypertensive drugs of choice (3, 4) . The report also recommended that when two or more antihypertensive agents are combined, one of the drugs should be a thiazide diuretic (3, 4) . On the other hand, the range of selected antihypertensives has been expanded, because agents with different mechanisms of action have been developed, including calcium channel blockers and renin-angiotensin (RA) modulators such as angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB). Consequently, the use of diuretics has greatly decreased due to concern over adverse metabolic reactions. There is therefore increasing momentum for reexamining the proper use of diuretics. This article is an attempt to elucidate the characteristics of hypertensive patients for whom a diuretic is indicated and to clarify the pathophysiological basis for selecting these drugs.
Mechanisms of the Hypotensive Action of Diuretics
Fundamental to the action of thiazide diuretics is the enhancement of urinary sodium excretion through the inhibition of Na-Cl co-transport in the distal renal tubules. The precise mechanisms by which the inhibition of renal sodium reabsorption lowers blood pressure (BP) remain unknown. We have proposed that one of the following conditions is necessary to elevate BP and cause hypertension: 1) an increase in vascular resistance between the heart and the glomeruli; 2) a decrease in the glomerular filtration capability; or 3) an enhancement in renal sodium reabsorption by tubules (5) . The first of these three conditions creates sodium-insensitive hypertension, while the latter two create sodium-sensitive hypertension (5) . Considering the opposite of case 3), of itself, is useful for elucidating the hypotensive mechanism of diuretics ( Fig. 1 ) (6) (7) (8) . If the glomerular filtration rate (GFR) and the tubular sodium load are normal, inhibition of the tubular sodium reabsorption by a diuretic makes the sodium balance negative. Consequently, both the body fluid volume and BP decrease. A reduction in glomerular capillary pressure accompanying the reduction in systemic BP results in decreases in GFR and tubular sodium load, thereby maintaining sodium balance against the inhibited sodium reabsorption. Thus, it is understood that an inhibition of tubular sodium reabsorption as occurs with the use of a diuretic necessitates reductions in BP and essentially in tubular sodium load to maintain sodium balance (6) (7) (8) . In fact, a recent report demonstrated a reduction in glomerular capillary pressure with diuretics (9) . Diuretics frequently induce an elevation of serum creatinine. This reflects inevitable functional changes necessitated by decreases in GFR, glomerular capillary pressure and tubular sodium load with diuretic treatment, as discussed above. In the recent ALLHAT (1) and INSIGHT (10, 11) studies, decreased GFR was confirmed in the groups treated with diuretics. Reflecting a reduction in glomerular capillary pressure, however, elevated serum creatinine suggests a renoprotective effect, which was of concern a decade ago, when RA modulators were in wide use (12) . In fact, a reduction in urinary protein equal to that seen with RA modulators was recently demonstrated with diuretics (13, 14) . This is a noteworthy point that must be examined in the future by largescale clinical studies.
Effect of Diuretics on the Pressure-Natriuresis Curve
The relationship between sodium balance and BP, mentioned above, is expressed well by Guyton's pressure-natriuresis curve (15) (16) (17) . We examined the hypotensive effect of the thiazide diuretic, mefruside, based on this curve (Fig. 2) (6) . Mefruside increased the slope of the pressure-natriuresis curve, but did not result in a significant change in the inter- Saito and Kimura (6) ).
cept of the BP axis. This finding suggests that the hypotensive effect of diuretics is based mainly on the increase in the slope of the curve by multiplying the rate of sodium excretion per unit change in BP. Therefore, diuretic treatment enables the maintenance of sodium balance at lower levels of BP, GFR and tubular sodium load (6) (7) (8) . Among life-style modifications, the Dietary Approaches to Stop Hypertension (DASH) diet, which is rich in vegetables, fruits, and low-fat dairy products, has drawn attention as one of the approaches with the greatest hypotensive effect (18) (19) (20) . The effectiveness of the DASH diet is based on its diuretic action (8) , and the diet thus appears to be a natural diuretic (8) .
The reciprocal of the slope of the pressure-natriuresis curve represents the change in BP when sodium intake is modified. In other words, it represents the sodium sensitivity of BP (5, 21) . Therefore, we can also imagine that diuretics exert their hypotensive effect by reducing sodium sensitivity, as reflected in the fact that a stronger hypotensive effect is recognized in patients with a more depressed slope of the pressure-natriuresis curve and higher sodium sensitivity (6, 8, 20) .
Mechanism of Resistance to Diuretics
We next turn to the question of why there are differences in hypotensive effect among patients in whom a similar diuretic action is seen, and will examine the phenomenon whereby no significant hypotensive effect is seen despite the occurrence of a diuretic action, i.e., the mechanism of diuretic resistance.
To maintain sodium balance with inhibited tubular sodium reabsorption under diuretic administration, the tubular sodium load must be reduced. Specifically, glomerular capillary pressure and GFR should be reduced. If BP does not decrease in this case, a large pressure difference must be developed between the systemic circulation and glomerular capillaries. An increase in vascular resistance between the heart and glomeruli, mainly in the afferent arterioles, as a result of diuretic administration prevents manifestation of the hypotensive effect of the drug (Fig. 3) .
Although the precise mechanism of diuretic resistance due to the increase in afferent arteriolar resistance is not clear, it has been speculated that stimulation of the sympathetic nerve and RA systems as well as tubulo-glomerular feedback are involved. For example, thiazide diuretics, which promote natriuresis downstream from the macula densa, have a strong hypotensive effect despite their weak diuretic action. On the other hand, loop diuretics, which act before reaching the macula densa, have a weak hypotensive effect despite their potent diuretic action, because they inhibit NaCl transport in the macula densa and thereby stimulate the RA system. Under conditions where these factors are strongly in effect, the pressure-natriuresis curve is usually shifted rightward without depressing the slope. A steep slope is characteristic of sodium insensitivity of BP (5, 21, 22) . As mentioned previously, the shallower the slope of the pretreatment pressure-natriuresis curve and the greater the sodium sensitivity of BP, the greater the improvement in the slope and the greater the hypotensive effect of diuretic therapy (6, 8) . Conversely, patients with a pressure-natriuresis curve with a steeper slope and sodium insensitivity are resistant to diuretics in addition to sodium intake restriction (6, 8, 22) . The factors suggestive of diuretic resistance are summarized in Table 1 . 
Fig. 3. Estimated changes in glomerular hemodynamics with diuretic administration. The changes in glomerular hemodynamics with diuretics were compared between responders for whom a favorable hypotensive effect was obtained (left) and resistant patients for whom this effect was not obtained (right). Note that vascular resistance in the afferent arterioles varies greatly between the two groups. In resistant patients, reduction in vascular resistance

Indications for Diuretic Therapy Based on the Pressure-Natriuresis Curve
During early onset of essential hypertension, the slope of the pressure-natriuresis curve is generally normal and steep with a slight rightward shift in parallel (Fig. 4 ) (23) (24) (25) . In other words, the patients are sodium-insensitive. By contrast, as hypertension progresses from moderate to severe, the pressure-natriuresis curve is gradually shifted further rightward and its slope gradually decreases, resulting in higher sodium sensitivity of BP (23) (24) (25) . Taken together, this natural history of the pressure-natriuresis curve for essential hypertension and the above-mentioned effect of diuretics on the pressure-natriuresis curve clearly show the indication of diuretics on hypertension (6, 26) . In borderline or mild essential hypertension, the pressure-natriuresis curve is shifted rightward but the slope remains steep, indicating sodium insensitivity. Therefore, no significant hypotensive effect can be expected with diuretic therapy alone in these cases. In fact, in an investigation of the efficacy of monotherapy with various antihypertensive drugs in white patients below 60 years old, who are assumed to have a steep slope of the curve and therefore to be sodium insensitive, the efficacy rate for thiazide diuretics was around 30%, the lowest of the drug classes examined (27, 28) . In black patients older than 60 years, for whom the slope of the curve is assumed to be depressed and to be sodium sensitive, the highest efficacy rates were seen for calcium channel blockers and diuretics (27, 29) . The cardiovascular protection by treatment with thiazide diuretics in elderly hypertensive patients has been demonstrated in large clinical studies such as the SHEP study (30) (31) (32) . It is therefore easy to understand why international guidelines consider hypertension in elderly patients to be a positive indication for diuretic treatment (3, 4, (33) (34) (35) .
Diuretics Normalize Circadian Rhythm of Blood Pressure
In a study by Uzu and Kimura, the circadian BP rhythm was examined before and after administration of the thiazide diuretic, hydrochlorothiazide, once each morning for 4 weeks (36) . With the focus on the reduction in BP from daytime to nighttime, a significant reduction in nocturnal BP was seen in both the dipper and non-dipper groups. However, an interaction between the diuretic and the reduction in nocturnal BP was present only in the non-dipper group; no interaction was seen in the dipper group. These findings clearly show that the diuretic did not affect the reduction in nocturnal BP in dippers, but it enhanced the reduction in nocturnal BP in nondippers, shifting their circadian BP rhythm toward the dipper pattern ( Fig. 5) (36) . The non-dipper pattern of circadian BP rhythm, in which the reduction in nocturnal BP is impaired, is observed not only with essential hypertension (36) (37) (38) (39) , but also with primary aldosteronism (40) , hypertension in blacks (41, 42) , chronic kidney disease (43) , and diabetic nephropathy (38) , all of which are characterized by diminished renal functional reserve and high sodium sensitivity (44) . The same shift from non-dipper to dipper status, as recognized by dietary sodium intake restriction (38) , has also been confirmed with diuretics All of these, listed in this table, are factors that increase vascular resistance between the heart and glomeruli, at the same time resulting in sodium-insensitive hypertension. Conversely, factors that increase sodium sensitivity of blood pressure are advanced age, black ethnicity, female sex, obesity, and severe hypertension. Concomitant nephropathy clearly increases sodium sensitivity. Increased sodium sensitivity strengthens the hypotensive effect of diuretics. 
As the condition progresses to mild essential hypertension (mild EH) and severe essential hypertension (severe EH), the curves shift further rightward. At the same time, their slopes become depressed and shallower, with an observed shift toward sodium-sensitive hypertension (from Parfrey (23)).
(36), suggesting that the kidney's ability to excrete sodium plays an important role in determining the circadian BP rhythm (43, 44) .
A high risk of cardiovascular complications has repeatedly been reported for patients with hypertension who exhibit a non-dipper circadian BP rhythm (45) (46) (47) (48) (49) . This is consistent with the idea that nocturnal BP is more important than diurnal BP or 24-h average BP as a determining factor of cardiovascular events (50) (51) (52) . Recently, renal dysfunction has drawn attention as a potent risk factor or predictor for cardiovascular events (53) (54) (55) (56) (57) . Progression from microalbuminuria to albuminuria, renal dysfunction, and eventual end-stage renal failure as a function of renal functional loss is associated with a pronounced increase in cardiovascular events (58) . Moreover, these risk factors are independent of classical risk factors such as diabetes and hypertension. We previously found that the greater the decrease in GFR with chronic kidney disease, the greater the elevation in nocturnal BP, and that nocturnal urinary sodium and protein excretions increased at the same time (43) . In kidney transplantation donors, nocturnal BP increased in proportion to the decrease in GFR following unilateral nephrectomy (59) . These findings have prompted speculation that a decrease in renal function prevents waste products and sodium from being completely excreted during the daytime and that BP reduction at night must be suppressed in order to vigorously drive nighttime renal function, which results in the non-dipper pattern (44, 60) . We propose that this non-dipper circadian BP rhythm would give rise to cardiovascular events as a function of renal functional loss (60) . This hypothesis is consistent with reports that the non-dipper pattern was observed in patients with sodium-sensitive hypertension (36, 38, 44) , who are at high risk for cardiovascular events (61) (62) (63) .
The fact that, like sodium intake restriction (38) , diuretics normalize the circadian BP rhythm from a non-dipper to a dipper-type pattern (36) must be noted as one of the potent mechanisms by which diuretics reduce cardiovascular events.
Low-Dose Diuretics and Their Significance in Combination Therapies
Based on these findings, it seems clear that resistance to the hypotensive effect of diuretics is caused not by a weakening of the diuretic response to these drugs, but rather by excessive constriction of the afferent arterioles. Therefore, diuretic resistance should be handled not by rashly increasing the dose of the diuretic, but rather by switching to another drug or administering the diuretic in combination with the other drugs. In fact, it has been shown that reducing the dose to 1/8 of the conventional dose results in little change in the hypotensive effect (64, 65) . It should be noted that a nearly full hypotensive effect of diuretics is obtained with a low dose; thus, the effect is not dose-dependent (64) . Patients with sodium sensitivity, who are thought to achieve a favorable effect from diuretic therapy, are generally older and severely hypertensive, and they often have decreased cardiac output and organ blood flow. It is therefore recommended that the lowest effective diuretic dose be used and that the diuretic be administered in combination with a calcium channel blocker or RA modulator that has a vasodilatory effect (6, 25, 26) . In keeping with the rationale described above (see Fig. 3 ), these vasodilatory agents will likely release afferent arteriolar vasoconstriction and potentiate the hypotensive effect of the diuretic. This will be discussed in detail in a later section describing the algorithm for concomitant use (below).
Diuretics such as thiazides are known to dose-dependently elicit adverse reactions such as hypokalemia, hypomagnesemia, hyperuricemia, hyperlipidemia and glucose intolerance (64) . Antihypertensive therapy with thiazide diuretics also has been shown to increase the risk of sudden death in a dose-dependent fashion (65) . It has been suggested that to reduce this risk, either the thiazide dose must be reduced or a potassium-sparing diuretic must be concomitantly administered (65) . Caution should be exercised regarding reports indicating the absence of an inhibition of cardiovascular events in cases where hypokalemia occurs even at a low dose (66) . Recently, there have been reports suggesting that while the likelihood of new-onset diabetes mellitus clearly increases with diuretic use, this increase is not necessarily linked to cardiovascular events or death (67, 68) .
Fig. 5. Normalization of circadian blood pressure (BP) rhythm by diuretics. Effects of a thiazide diuretic, hydrochlorothiazide, on circadian BP rhythm were compared between dippers (left) and non-dippers (right). Dippers showed a significant reduction in nocturnal BP independently of administration of the diuretic. In contrast, in non-dippers, the previously impaired reduction in nocturnal BP was restored by the diuretic. Moreover, a significant interaction was seen between the reduction in nocturnal BP and diuretic administration (p< 0.001), with the reduction being enhanced by the diuretic. Thus, the diuretic clearly shifted the circadian BP rhythm from the non-dipper type to the normal dipper type. MAP, mean arterial pressure (from Uzu and Kimura (36)).
In any case, low-dose diuretic therapy confers an adequate hypotensive effect, with only adverse reactions increasing dose-dependently (66, 69) .
Thus, it is recommended that antihypertensive diuretics such as the thiazides be administered in combination with various other antihypertensive drugs rather than alone, and that they be administered at a low dose.
New Algorithm for Concomitant Administration
The best known algorithm for determining desirable combinations of antihypertensive drugs is that proposed in the 2003 ESH/ESC Guidelines (33). We simplified this algorithm to create a more practical model (Fig. 6) . First, α-blockers are eliminated, because they are almost never used as first-line agents (1, 3, 4) . Keep in mind, however, that β-blockers are the only drugs desirable for concomitant use with α-blockers. Next, attention is focused on the fact that concomitant use of ACE inhibitors and ARBs is undesirable from the perspective of antihypertensive efficacy (70) . Moreover, the method for combining an ACE inhibitor or ARB with a desirable concomitant drug is the same. Therefore, if these two types of drugs are combined as RA modulators, the algorithm can be simplified as indicated in the center of Fig. 6 . In addition, the need arose to modify the algorithm for concomitant use of β-blockers and diuretics. In the LIFE study, although equal reductions in BP were seen in the ARB group and the β-blocker group, the inhibition of cardiovascular events in the former was significantly better than that in the latter (71, 72) .
A subsequent repeat analysis of this study showed that the rate of concomitant diuretic use was approximately 70% in both groups (73) . β-Blockers and diuretics both have pharmacologic effects that reduce cardiac output (26) . This suggests that concomitant use of these drugs may have increased the rate of cardiovascular events such as stroke (71, 72) , and probably cerebral infarction, due to a decrease in organ blood flow. The combination of diuretics and ARBs, the latter of which increase cardiac output, appears to bring out the strengths of each type of drug (26) . The recently published ASCOT-BPLA study can be interpreted in the same manner (74) . In this study, as compared with concomitant administration of a β-blocker and a diuretic, the combination of a calcium channel blocker and an ACE inhibitor significantly inhibited cardiovascular events. The fact that there was a difference in stroke occurrence that could not be explained by correcting for factors such as BP (75) suggests that organ blood flow may have decreased with the former combination.
With concomitant administration of diuretics and β-blockers, there is also concern that abnormal glucose metabolism may be exacerbated (34, 68, 71, 74) . Based on these evidences, it was determined that combining diuretics and β-blockers is undesirable, and the algorithm was modified accordingly. The final form of the algorithm is shown in the right side of Fig. 6 . Examining this algorithm with a focus on diuretics serves as a reminder that the drugs for concomitant use are limited to RA modulators and calcium channel blockers. Because both types of drugs are vasodilators, they can both maintain organ blood flow while potentiating the hypotensive effect of the diuretic by releasing afferent arteriolar vasoconstriction, the key to inducing diuretic resistance. Rates of concomitant diuretic administration were examined in clinical trials provided in the JNC 7 guidelines in the U.S. as organ protection by RA modulators (3, 4) . It is of particular interest that, for both ACE inhibitors and ARBs, diuretics were used as concomitant drugs in nearly all of the studies on heart failure, chronic kidney disease and stroke. These findings may suggest that concomitant use of diuretics and RA modulators, rather than RA modulators alone achieved a protective effect. It is assumed that the combination of the two types of drugs is advantageous in that each drug counteracts the adverse reactions of the other and that they synergistically potentiate their hypotensive effects (6, 8, 25, 26, 76) . It would also be of interest to examine whether these kinds of advantages exist with concomitant use of calcium channel blockers and diuretics. Regarding therapy focused on modulators of the RA system, large comparative clinical studies examining whether concomitant diuretic use is beneficial, as in the LIFE study (71, 72) , and whether concomitant calcium channel blocker use is beneficial, as in the ASCOT study (74, 75) , are anticipated in the future. 
Changes over Time in the Quantity of Diuretics Prescribed
Sales of diuretics in the U.S., although once on the decline, have been increasing since 1996, and diuretics are now the most frequently prescribed hypotensive agents in the U.S. (77) . It has been speculated that this reversal reflects the recognition of their ability, in lower doses, to provide excellent organ protection, hypotensive efficacy and reduced adverse reactions, as well as their economic advantages. In contrast, sales of diuretic agents in Japan have remained nearly flat at a minimum level over the last 10 years, while those of calcium channel blockers have continued to increase, and those of ARBs have recently increased rapidly. A possible reason for the decrease in diuretic use in Japan is that the advantages of low-dose diuretic therapy have not yet been experienced in this country. The hypotensive effect of diuretics peaks at a low dose and thus is not dose-dependent, while adverse reactions increase in a dose-dependent fashion (64) . In Japan, experience with diuretics has been limited to highdosages. It is therefore likely that the adverse reactions have been the most prominent aspect of diuretic therapy, resulting in a poor assessment of hypotensive diuretics. However, sodium intake in Japan is among the highest in the world, and sodium sensitivity of BP is presumed to be high in the Japanese. Therefore, it will be particularly important to carefully reexamine the proper use of diuretics in Japanese. It will also be important to vigorously promote the adoption of the DASH diet (8, 18, 19) , a natural diuretic that does not elicit hypokalemia or any other adverse reactions and that is healthy for all individuals. In any event, the era of rashly avoiding diuretic use appears to have ended.
Perspectives
There are a variety of views on how to select an appropriate agent when initiating hypotensive drug therapy. These are based on perspectives such as organ protection, a metabolic viewpoint that neither new onset of diabetes mellitus nor atherosclerosis is promoted and the need to avoid certain drugs, depending on the underlying disease or organ damage. We previously reported that the sodium sensitivity of BP occurring with diminished renal functional reserve reflects a predisposition to cardiovascular complications (61, 62) . Diabetes mellitus and nephropathy increase sodium sensitivity. Decreasing the sodium load in sodium-sensitive patients with diuretics not only greatly reduces systemic BP but also normalizes the circadian BP rhythm, thus shifting from a nondipper to a dipper pattern. It is also expected to reduce other types of loads, such as glomerular hypertension (14, 36) .
Thus, it appears that diuretics are essential for the treatment of a variety of pathophysiological conditions, and that the key to using these drugs is administration at low doses in combination with other drugs. If used properly, by taking into account the pathophysiology of the individual, diuretics will continue to play an important role in the treatment of hypertension.
